chr1-25303329-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP5BP4BS2_Supporting
The NM_016124.6(RHD):āc.809T>Gā(p.Val270Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00382 in 1,368,616 control chromosomes in the GnomAD database, including 1,434 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: š 0.0025 ( 81 hom., cov: 21)
Exomes š: 0.0040 ( 1353 hom. )
Consequence
RHD
NM_016124.6 missense
NM_016124.6 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 4.62
Genes affected
RHD (HGNC:10009): (Rh blood group D antigen) The Rh blood group system is the second most clinically significant of the blood groups, second only to ABO. It is also the most polymorphic of the blood groups, with variations due to deletions, gene conversions, and missense mutations. The Rh blood group includes this gene, which encodes the RhD protein, and a second gene that encodes both the RhC and RhE antigens on a single polypeptide. The two genes, and a third unrelated gene, are found in a cluster on chromosome 1. The classification of Rh-positive and Rh-negative individuals is determined by the presence or absence of the highly immunogenic RhD protein on the surface of erythrocytes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
PP5
Variant 1-25303329-T-G is Pathogenic according to our data. Variant chr1-25303329-T-G is described in ClinVar as [Pathogenic]. Clinvar id is 17713.Status of the report is no_assertion_criteria_provided, 0 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.01566735). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAd4 at 81 BG geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHD | NM_016124.6 | c.809T>G | p.Val270Gly | missense_variant | 6/10 | ENST00000328664.9 | NP_057208.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHD | ENST00000328664.9 | c.809T>G | p.Val270Gly | missense_variant | 6/10 | 1 | NM_016124.6 | ENSP00000331871 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00251 AC: 332AN: 132056Hom.: 82 Cov.: 21
GnomAD3 genomes
AF:
AC:
332
AN:
132056
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00254 AC: 565AN: 222276Hom.: 149 AF XY: 0.00245 AC XY: 294AN XY: 119938
GnomAD3 exomes
AF:
AC:
565
AN:
222276
Hom.:
AF XY:
AC XY:
294
AN XY:
119938
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00396 AC: 4896AN: 1236442Hom.: 1353 Cov.: 28 AF XY: 0.00388 AC XY: 2394AN XY: 617322
GnomAD4 exome
AF:
AC:
4896
AN:
1236442
Hom.:
Cov.:
28
AF XY:
AC XY:
2394
AN XY:
617322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00250 AC: 330AN: 132174Hom.: 81 Cov.: 21 AF XY: 0.00223 AC XY: 144AN XY: 64714
GnomAD4 genome
AF:
AC:
330
AN:
132174
Hom.:
Cov.:
21
AF XY:
AC XY:
144
AN XY:
64714
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
34
ExAC
AF:
AC:
295
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Rhd, weak d, type I Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1999 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T;T;T;T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;M;M;M;.;M;.
MutationTaster
Benign
A;A;A;A;A;A;A
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;.;.;D;D;D;D;D;D
REVEL
Benign
Sift
Uncertain
D;.;.;D;D;D;D;D;D
Sift4G
Pathogenic
D;.;D;D;D;D;D;D;D
Polyphen
B;.;B;.;.;.;.;.;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at